MYRIAD GENETICS, INC. Impairment of Intangible Assets, Finite-lived
MYRIAD GENETICS, INC. (MYGN) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2025-02-28
- MYRIAD GENETICS, INC. impairment of intangible assets, finite-lived for the quarter ending 2013-06-30 was $10.00K.
- MYRIAD GENETICS, INC. impairment of intangible assets, finite-lived for the quarter ending 2013-03-31 was $0.00.
- MYRIAD GENETICS, INC. impairment of intangible assets, finite-lived for fiscal 2023 was $0.00.
- MYRIAD GENETICS, INC. impairment of intangible assets, finite-lived for fiscal 2022 was $0.00.
- MYRIAD GENETICS, INC. impairment of intangible assets, finite-lived for fiscal 2013 was $1.50M.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | ||||
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 | ||||
| 2013-06-30 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $10.00K derived: sum of 2 quarters · filed 2015-08-12 | $1.50M 10-K · filed 2015-08-12 | $1.49M 10-K · filed 2013-08-14 | |
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07 | $1.49M 10-Q · filed 2014-05-07 | |||
| 2012-12-31 | $1.49M 10-Q · filed 2014-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |